Overview

Efficacy and Safety of Ferrous Iron on the Prevention of Vascular Cognitive Impairment Among Patients With Cerebral Infarction/TIA (FAVORITE)

Status:
Recruiting

Trial end date:
2021-12-31

Target enrollment:

Participant gender:

Summary

The prevalence of Vascular Cognitive Impairment(VCI) is high in patients after ischemic stroke or transient ischemic attack(TIA) . Effective therapy for the prevention of VCI remains limited. The primary purpose of this study is to evaluate the efficacy and safety of Ferrous iron versus placebo on the prevention of vascular cognitive impairment among patients with ischemic stroke/TIA complicated with Hemoglobin deficiency.

Phase:

Phase 2

Details

Lead Sponsor:

Beijing Tiantan Hospital
Yongjun Wang, MD

Treatments:

Ferrous succinate
Iron